-Ming Zhao Researcher Activity Profile

Research Author Detailed Information 

Ming Zhao Publication Rate By Year

Ming Zhao has published 2 paper(s) in 2002, 2 paper(s) in 2003, 1 paper(s) in 2004, 1 paper(s) in 2005, 10 paper(s) in 2006, 56 paper(s) in 2007, 10 paper(s) in 2008, for a total of 82 research publications in total.

Ming M Zhao Author Information

LAST NAME: zhao

FIRST NAME: ming

INITIALS: M

AFFILIATION:

Papers

Ming Zhao's Publication Record

1. Utp14b: a unique retrogene within a gene that has acquired multiple promoters and a specific function in spermatogenesis. Year Published: 2007
Department of Experimental Radiation Oncology, University of Texas M.D. Anderson Cancer Center, Box 066, 1515 Holcombe Blvd, Houston, TX 77030, USA.
2. [Inhibitory effects of reduced glutathione sodium on renal nuclear factor-kappaB expression in rats with diabetes of different stages] Year Published: 2007
Department of Endocrinology, Nanjing General Hospital of Nanjing Command, Nanjing 210002, China.
3. Alpha-tocopheryl succinate, an agent with in vivo anti-tumour activity, induces apoptosis by causing lysosomal instability. Year Published: 2002
4. Bone morphogenetic protein 2 induces dental follicle cells to differentiate toward a cementoblast/osteoblast phenotype. Year Published: 2002
Department of Periodontics/Prevention/Geriatrics, School of Dentistry, University of Michigan, Ann Arbor 48109-1078, USA.
5. NF-kappaB specifically activates BMP-2 gene expression in growth plate chondrocytes in vivo and in a chondrocyte cell line in vitro. Year Published: 2003
Department of Oral Biology, School of Dentistry, University of Missouri, Kansas City, Missouri 64108, USA.
6. Exploring the origins of cementoblasts and their trigger factors. Year Published: 2003
Department of Periodontics/Prevention/Geriatrics, School of Dentistry, University of Michigan, Ann Arbor, Michigan 48109-1078, USA. jeberry@umich.edu
7. Bone morphogenetic proteins. Year Published: 2004
School of Medicine and Dentistry, Department of Orthopaedics, University of Rochester, Rochester, NY 14642, USA.
8. [Screening and identification of steroidal saponins-producing endophytes from Paris polyphylla var. chinensis Franch] Year Published: 2005
College of Life Sciences, Sichuan Normul University, Chengdu, China.
9. [CT guided radioactive seed 125I implantation in treatment of pancreatic cancer] Year Published: 2006
Department of Imaging and Interventional Radiology, State Key Laboratory of Oncology in Southern China.
10. The zinc finger transcription factor Gli2 mediates bone morphogenetic protein 2 expression in osteoblasts in response to hedgehog signaling. Year Published: 2006
Department of Cellular and Structural Biology, University of Texas Health Science Center, 7703 Floyd Curl Drive, San Antonio, TX 78229, USA. zhaom0@uthscsa.edu
11. Validation and implementation of a liquid chromatography/tandem mass spectrometry assay to quantitate ABT-751, ABT-751 glucuronide, and ABT-751 sulfate in human plasma for clinical pharmacology studies. Year Published: 2006
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA. mrudek2@jhmi.edu
12. Deleted in colorectal cancer is a putative conditional tumor-suppressor gene inactivated by promoter hypermethylation in head and neck squamous cell carcinoma. Year Published: 2006
Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins Medical Institutions, Baltimore, MD 21287-0910, USA.
13. Use of a stringent dimerizer-regulated gene expression system for controlled BMP2 delivery. Year Published: 2006
Department of Periodontics and Oral Medicine, School of Dentistry, and Center for Craniofacial Regeneration, School of Medicine, University of Michigan, Ann Arbor, MI 48109, USA.
14. [Short-term curative efficacy of cytokine-induced killer cells combined micro-invasive treatments on hepatocellular carcinoma] Year Published: 2006
State Key Laboratory of Oncology in South China, Guangzhou, Guangdong, 510060, P. R. China.
15. [Detection of serum interleukin-6 level in patients with multiple myeloma of Vighur nationality and Han nationality and its clinical significance] Year Published: 2006
Department of Hemotology, Xinjiang Vighur Autonomous Region People Hospital, Urumqi 830001, China.
16. A liquid chromatography/tandem mass spectrometry assay to quantitate MS-275 in human plasma. Year Published: 2006
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA.
17. Phase I study of continuous weekly dosing of dimethylamino benzoylphenylurea (BPU) in patients with solid tumours. Year Published: 2007
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Bunting-Blaustein Cancer Research Building, CRB 1M88, 1650 Orleans Street, Baltimore, MD 21231, USA. wmesser1@jhmi.edu
18. Angiotensin II receptor blocker provides pancreatic beta-cell protection independent of blood pressure lowering in diabetic db/db mice. Year Published: 2007
Department of Endocrinology and Metabolism, Nanjing General Hospital of Nanjing Command, Nanjing 210002, China. shaojiaq@hotmail.com
19. A rapid and sensitive method for determination of sorafenib in human plasma using a liquid chromatography/tandem mass spectrometry assay. Year Published: 2007
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA.
20. The mouse dead-end gene isoform alpha is necessary for germ cell and embryonic viability. Year Published: 2007
University of Texas, MD Anderson Cancer Center, Department of Cancer Genetics, Houston, TX 77030, USA.
21. Neurocyte apoptosis and expressions of caspase-3 and Fas after spinal cord injury and their implication in rats. Year Published: 2007
Department of Orthopedics,Union Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan 430022, China.
22. Regulation of human lung adenocarcinoma cell migration and invasion by macrophage migration inhibitory factor. Year Published: 2007
Molecular Targets Program, J. G. Brown Cancer Center, University of Louisville, Louisville, Kentucky 40202, USA.
23. [Apoptosis induction of rhesus peripheral blood lymphocytes] Year Published: 2007
Department of Organ Transplantation, Zhujiang Hospital, Southern Medical University, Guangzhou 510282, China. flp777@163.com
24. [Environmental radiation dose monitor after 125I radioactive seed implantation] Year Published: 2007
State Key Laboratory of Oncology in South China, Guangzhou, Guangdong 510060, P. R. China.
25. Monotherapy with a tumor-targeting mutant of Salmonella typhimurium cures orthotopic metastatic mouse models of human prostate cancer. Year Published: 2007
AntiCancer Inc., 7917 Ostrow Street, San Diego, CA 92111, USA.
26. Differential metabolism of gefitinib and erlotinib by human cytochrome P450 enzymes. Year Published: 2007
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, USA.
27. [Metalloproteinase-9/tissue inhibitor of metalloproteinase-1 in induced sputum in patients with asthma and chronic obstructive pulmonary disease and their relationship to airway inflammation and airflow limitation] Year Published: 2007
Department of Pulmonary Diseases, Nanjing General Hospital of Nanjing Command, PLA, Nanjing 210002, China.
28. Forkhead proteins are critical for bone morphogenetic protein-2 regulation and anti-tumor activity of resveratrol. Year Published: 2007
Graduate Institute of Cancer Biology, College of Medicine, China Medical University, Taichung 404, Taiwan.
29. [Effects of angiotensin II type 1 receptor blocker on islet of diabetic db/db mice] Year Published: 2007
Department of Endocrinology and Metabolism, Nanjing General Hospital of Nanjing Military Command, Nanjing 210002, China.
30. [Heterosis of photosynthetic performance of maize] Year Published: 2007
College of Agronomy and Bio-technology, China Agricultural University, Beijing 100094, China. lisa210@163.com
31. Differential phase-contrast BioCD biosensor. Year Published: 2007
Department of Physics, Purdue University, West Lafayette, Indiana 47907-2036, USA. zhaom@purdue.edu
32. Validation and implementation of a liquid chromatography/tandem mass spectrometry assay to quantitate ON 01910.Na, a mitotic progression modulator, in human plasma. Year Published: 2007
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD 21231, USA.
33. Transcriptional profiling of human embryonic stem cells and embryoid bodies identifies HESRG, a novel stem cell gene. Year Published: 2007
Cancer Research Institute, Xiang-Ya School of Medicine, Central South University, 110 Xiangya Road, Changsha 410078, Hunan, and Department of Neurosurgery, Xiangya Hospital, China.
34. Macrophages suppress T cell responses and arthritis development in mice by producing reactive oxygen species. Year Published: 2007
Section of Medical Inflammation Research, Lund University, Lund, Sweden.
35. Stimulation of new bone formation by the proteasome inhibitor, bortezomib: implications for myeloma bone disease. Year Published: 2007
Department of Cellular and Structural Biology, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA. oyajobi@uthscsa.edu
36. Induction of apoptosis underlies the Radix Rubiae-mediated anti-proliferative action on human epidermal keratinocytes: implications for psoriasis treatment. Year Published: 2007
School of Chinese Medicine, Faculty of Science, The Chinese University of Hong Kong, Shatin, N.T, Hong Kong SAR, P.R. China.
37. Regulation of human lung adenocarcinoma cell migration and invasion by macrophage migration inhibitory factor. Year Published: 2007
Molecular Targets Program, J. G. Brown Cancer Center, University of Louisville, Louisville, Kentucky 40202, USA.
38. Dual-acting agents that possess reversing resistance and anticancer activities: Design, synthesis, MES-SA/Dx5 cell assay, and SAR of Benzyl 1,2,3,5,11,11a-hexahydro-3,3-dimethyl-1-oxo-6H-imidazo[3',4':1,2]pyridin[3,4-b]indol-2-substitutedacetates. Year Published: 2007
College of Pharmaceutical Sciences, Capital Medical University, Beijing 100069, PR China.
39. Induction of apoptosis by artemisinin relieving the severity of inflammation in caerulein-induced acute pancreatitis. Year Published: 2007
Department of General Surgery, First Clinical College, Harbin Medical University, Harbin 150001, Heilongjiang Province, China.
40. Contributing factors of temozolomide resistance in mcf-7 tumor xenograft models. Year Published: 2007
Department of Radiology, Division of MR Research, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
41. [Safety of perfused needle electrode radiofrequency ablation in the first and second portal region parenchyma in Swine.] Year Published: 2007
State Key Laboratory of Oncology in South China, Guangzhou, Guangdong, 510060, P. R. China. wupeihong@yahoo.com.
42. Common-path interferometric detection of protein monolayer on the BioCD. Year Published: 2007
43. Quantitative analysis of [(99m)Tc]C2A-GST distribution in the area at risk after myocardial ischemia and reperfusion using a compartmental model. Year Published: 2007
Department of Biomedical Engineering, Marquette University, Milwaukee, WI, USA.
44. In vivo dynamic imaging of myocardial cell death using (99m)Tc-labeled C2A domain of synaptotagmin I in a rat model of ischemia and reperfusion. Year Published: 2007
Department of Radiology, University of Arizona, Tucson, AZ 85724, USA.
45. SPECT imaging of myocardial infarction using (99m)Tc-labeled C2A domain of synaptotagmin I in a porcine ischemia-reperfusion model. Year Published: 2007
Department of Nuclear Medicine, Cardiovascular Institute and Fu Wai Hospital, Chinese Academy of Medical Sciences, Beijing 100037, China.
46. Novel N-(3-carboxyl-9-benzylcarboline-1-yl)ethylamino acids: synthesis, anti-proliferation activity and two-step-course of intercalation with calf thymus DNA. Year Published: 2007
College of Pharmaceutical Sciences, Peking University, Beijing 100083, P. R. China.
47. Downregulation of RAD17 in head and neck cancer. Year Published: 2007
Department of Otolaryngology-Head and Neck Surgery, Head and Neck Cancer Research Division, Johns Hopkins Medical Institutions, Baltimore, Maryland 21287.
48. [Heterosis of photosynthetic performance of maize] Year Published: 2007
College of Agronomy and Bio-technology, China Agricultural University, Beijing 100094, China. lisa210@163.com
49. PAK: an essential motif for forming beta-turn structures and exhibiting the thrombolytic effect of P6A and its analogs. Year Published: 2007
College of Chemical Biology and Pharmaceutical Sciences, Capital Medical University, Beijing 100069, PR, China.
50. Transcriptional profiling of human embryonic stem cells and embryoid bodies identifies HESRG, a novel stem cell gene. Year Published: 2007
Cancer Research Institute, Xiang-Ya School of Medicine, Central South University, 110 Xiangya Road, Changsha 410078, Hunan, and Department of Neurosurgery, Xiangya Hospital, China.
51. [Short-term curative efficacy of cytokine-induced killer cells combined micro-invasive treatments on hepatocellular carcinoma] Year Published: 2006
State Key Laboratory of Oncology in South China, Guangzhou, Guangdong, 510060, P. R. China.
52. Dual-acting agents that possess reversing resistance and anticancer activities: Design, synthesis, MES-SA/Dx5 cell assay, and SAR of Benzyl 1,2,3,5,11,11a-hexahydro-3,3-dimethyl-1-oxo-6H-imidazo[3',4':1,2]pyridin[3,4-b]indol-2-substitutedacetates. Year Published: 2007
College of Pharmaceutical Sciences, Capital Medical University, Beijing 100069, PR China.
53. Contributing factors of temozolomide resistance in MCF-7 tumor xenograft models. Year Published: 2007
Department of Radiology, Division of MR Research, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA. ykato@mri.jhu.edu
54. [Detection of serum interleukin-6 level in patients with multiple myeloma of Vighur nationality and Han nationality and its clinical significance] Year Published: 2006
Department of Hemotology, Xinjiang Vighur Autonomous Region People Hospital, Urumqi 830001, China.
55. Influence of CYP3A4 Inhibition on the Steady-State Pharmacokinetics of Imatinib. Year Published: 2007
Authors' Affiliations: Departments of Clinical Pharmacy and Toxicology and Clinical Oncology, Leiden University Medical Center, Leiden, the Netherlands.
56. Novel N-(3-carboxyl-9-benzyl-carboline-1-yl)ethylamino acids: synthesis, anti-proliferation activity and two-step-course of intercalation with calf thymus DNA. Year Published: 2007
College of Pharmaceutical Sciences, Peking University, Beijing 100083, P. R. China.
57. Human thrombopoietin reduces myocardial infarct size, apoptosis, and stunning following ischaemia/reperfusion in rats. Year Published: 2008
Division of Cardiothoracic Surgery, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI 53226, USA.
58. Clinical and molecular responses in lung cancer patients receiving romidepsin. Year Published: 2008
Authors' Affiliations:Thoracic Oncology Section Surgery Branch, Medical Oncology Branch, Biostatistics and Data Management Section, Center for Cancer Research and Cancer Therapy Evaluation Program, National Cancer Institute.
59. Alisolide, alisols O and P from the rhizome of Alisma orientale. Year Published: 2008
School of Chinese Medicine, The Chinese University of Hong Kong, Hong Kong.
60. Induction of apoptosis underlies the Radix Rubiae-mediated anti-proliferative action on human epidermal keratinocytes: implications for psoriasis treatment. Year Published: 2007
School of Chinese Medicine, Faculty of Science, The Chinese University of Hong Kong, Shatin, N.T, Hong Kong SAR, P.R. China.
61. Novel N-(3-carboxyl-9-benzyl-carboline-1-yl)ethylamino acids: synthesis, anti-proliferation activity and two-step-course of intercalation with calf thymus DNA. Year Published: 2007
College of Pharmaceutical Sciences, Peking University, Beijing 100083, P. R. China.
62. N-[2-(5,5-Dimethyl-1,3-dioxane-2-yl)ethyl]amino acids: Their synthesis, anti-inflammatory evaluation and QSAR analysis. Year Published: 2008
College of Pharmaceutical Sciences, Peking University, Beijing 100083, PR China.
63. [Safety of perfused needle electrode radiofrequency ablation in the first and second portal region parenchyma in swine] Year Published: 2007
State Key Laboratory of Oncology in South China, Guangzhou, Guangdong, 510060, PR China.
64. Minimally invasive treatment combined with cytokine-induced killer cells therapy lower the short-term recurrence rates of hepatocellular carcinomas. Year Published: 2007
State Key Laboratory of Oncology in Southern China, Biotherapy Center, Department of Imaging and Interventional Radiology, Sun Yat-Sen University, Guangzhou, Guangdong, P.R. China.
65. Differential phase-contrast BioCD biosensor. Year Published: 2007
Department of Physics, Purdue University, West Lafayette, Indiana 47907-2036, USA. zhaom@purdue.edu
66. Quantitative analysis of [99mTc]C2A-GST distribution in the area at risk after myocardial ischemia and reperfusion using a compartmental model. Year Published: 2007
Department of Biomedical Engineering, Marquette University, Milwaukee, WI, USA.
67. In vivo dynamic imaging of myocardial cell death using 99mTc-labeled C2A domain of synaptotagmin I in a rat model of ischemia and reperfusion. Year Published: 2007
Department of Radiology, University of Arizona, Tucson, AZ 85724, USA. zliu@radiology.arizona.edu
68. SPECT imaging of myocardial infarction using 99mTc-labeled C2A domain of synaptotagmin I in a porcine ischemia-reperfusion model. Year Published: 2007
Department of Nuclear Medicine, Cardiovascular Institute and Fu Wai Hospital, Chinese Academy of Medical Sciences, Beijing 100037, China.
69. Enhanced synchronizability via age-based coupling. Year Published: 2008
Department of Modern Physics, University of Science and Technology of China, Hefei 230026, China.
70. Downregulation of RAD17 in head and neck cancer. Year Published: 2007
Department of Otolaryngology-Head and Neck Surgery, Head and Neck Cancer Research Division, Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA.
71. Common-path interferometric detection of protein monolayer on the BioCD. Year Published: 2007
Department of Physics, Purdue University, 525 Northwestern Avenue, West Lafayette, Indiana 47907-2036, USA.
72. Influence of CYP3A4 inhibition on the steady-state pharmacokinetics of imatinib. Year Published: 2007
Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, the Netherlands.
73. Clinical and molecular responses in lung cancer patients receiving Romidepsin. Year Published: 2008
Thoracic Oncology Section Surgery Branch, Center for Cancer Research and Cancer Therapy Evaluation Program, National Cancer Institute, NIH, Bethesda, MD 20892, USA. david.schrump@nih.gov
74. Stimulation of new bone formation by the proteasome inhibitor, bortezomib: implications for myeloma bone disease. Year Published: 2007
Department of Cellular and Structural Biology, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA. oyajobi@uthscsa.edu
75. Dual-acting agents that possess reversing resistance and anticancer activities: Design, synthesis, MES-SA/Dx5 cell assay, and SAR of Benzyl 1,2,3,5,11,11a-hexahydro-3,3-dimethyl-1-oxo-6H-imidazo[3',4':1,2]pyridin[3,4-b]indol-2-substitutedacetates. Year Published: 2007
College of Pharmaceutical Sciences, Capital Medical University, Beijing 100069, PR China.
76. PAK: an essential motif for forming beta-turn structures and exhibiting the thrombolytic effect of P6A and its analogs. Year Published: 2007
College of Chemical Biology and Pharmaceutical Sciences, Capital Medical University, Beijing, PR, China.
77. Toward the development of chemoprevention agents (III): Synthesis and anti-inflammatory activities of a new class of 5-glycylamino-2-substituted-phenyl-1,3-dioxacycloalkanes. Year Published: 2008
College of Pharmaceutical Sciences, Capital Medical University, Beijing 100069, PR China.
78. Toward the development of chemoprevention agents (III): synthesis and anti-inflammatory activities of a new class of 5-glycylamino-2-substituted-phenyl-1,3-dioxacycloalkanes. Year Published: 2008
College of Pharmaceutical Sciences, Capital Medical University, Beijing 100069, PR China.
79. Whole-body imaging of bacterial infection and antibiotic response. Year Published: 2007
AntiCancer Incorporated, 7917 Ostrow Street, San Diego, California, 92111, USA. all@anticancer.com
80. Erratum: PAK: an essential motif for forming beta-turn structures and exhibiting the thrombolytic effect of P6A and its analogs. Year Published: 2008
College of Chemical Biology and Pharmaceutical Sciences, Capital Medical University, Beijing 100054, PR, China.
81. Clinical and molecular responses in lung cancer patients receiving Romidepsin. Year Published: 2008
Thoracic Oncology Section Surgery Branch, Center for Cancer Research and Cancer Therapy Evaluation Program, National Cancer Institute, NIH, Bethesda, MD 20892, USA. david.schrump@nih.gov
82. Downregulation of RAD17 in head and neck cancer. Year Published: 2007
Department of Otolaryngology-Head and Neck Surgery, Head and Neck Cancer Research Division, Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA.